Abstract
A consecutive series of 200 Choyce-Tennant rigid anterior chamber intraocular lens implants is reported. The minimum follow-up was four years. Eighty-six percent of patients had 20/40 or better visual acuity at their most recent office visit. Low-grade but persistent inflammation required prolonged use of mild topical steroid drops in approximately 40% of patients. The most serious lens-related complication was pupillary block which occurred in 15 patients (7.5%). There was a year-by-year increase in the number of patients with elevated intraocular pressure, with 14 (7.0%) requiring glaucoma treatment by the seventh year postoperatively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
